Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Lambert

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Plos One|October 3, 2013
The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivoZoë L S Brookes, Emily N Stedman, Nicola J Brown, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 19, 2002
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studiesRaffaella Bigoni, Daniela Rizzi, Anna Rizzi, et al.
Ultrasound (Leeds, England)|May 1, 2019
A preclinical ultrasound method for the assessment of vascular disease progression in murine modelsJustyna Janus, Baris Kanber, Wadhah Mahbuba, et al.
Peptides|May 26, 2009
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptorMadura Batuwangala, Valeria Camarda, John McDonald, et al.
Pharmacological Reviews|December 24, 2014
International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to functionHubert Vaudry, Jérôme Leprince, David Chatenet, et al.
Peptides|September 12, 2006
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studiesRaffaella Vergura, Elena Valenti, Christopher P Hebbes, et al.
Bioorganic & Medicinal Chemistry|May 11, 2007
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acidsMarika Arduin, Barbara Spagnolo, Girolamo Calò, et al.
Bioorganic & Medicinal Chemistry|June 17, 2009
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamideClaudio Trapella, Carmela Fischetti, Michela Pela', et al.
British Journal of Pharmacology|May 16, 2002
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptorGirolamo Calo, Anna Rizzi, Daniela Rizzi, et al.
Peptides|December 11, 2007
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonistRaffaella Vergura, Gianfranco Balboni, Barbara Spagnolo, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Plos One|October 3, 2013
The nociceptin/orphanin FQ receptor antagonist UFP-101 reduces microvascular inflammation to lipopolysaccharide in vivoZoë L S Brookes, Emily N Stedman, Nicola J Brown, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 19, 2002
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studiesRaffaella Bigoni, Daniela Rizzi, Anna Rizzi, et al.
Ultrasound (Leeds, England)|May 1, 2019
A preclinical ultrasound method for the assessment of vascular disease progression in murine modelsJustyna Janus, Baris Kanber, Wadhah Mahbuba, et al.
Peptides|May 26, 2009
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptorMadura Batuwangala, Valeria Camarda, John McDonald, et al.
Pharmacological Reviews|December 24, 2014
International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to functionHubert Vaudry, Jérôme Leprince, David Chatenet, et al.
Peptides|September 12, 2006
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studiesRaffaella Vergura, Elena Valenti, Christopher P Hebbes, et al.
Bioorganic & Medicinal Chemistry|May 11, 2007
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acidsMarika Arduin, Barbara Spagnolo, Girolamo Calò, et al.
Bioorganic & Medicinal Chemistry|June 17, 2009
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamideClaudio Trapella, Carmela Fischetti, Michela Pela', et al.
British Journal of Pharmacology|May 16, 2002
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptorGirolamo Calo, Anna Rizzi, Daniela Rizzi, et al.
Peptides|December 11, 2007
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonistRaffaella Vergura, Gianfranco Balboni, Barbara Spagnolo, et al.
Pageof 10